GlassScriptPhysician profile
Chima O Ohaegbulam
NPI 1164424693
$10,951.83
in general payments reported to CMS, 2019-2025
8 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $948 · 2020: $9,744 · 2021: $24.34 · 2022: $17.09 · 2023: $143 · 2024: $75.44.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $218.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $218.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $10,692.11 | 2019-2020 | |
| Augmedics INC. | $142.85 | 2023 | Xvision |
| Globus Medical, INC. | $24.34 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $22.41 | 2024 | Exparel, Zilretta, Iovera |
| Axogen | $19.17 | 2024 | Axoguard Nerve Connector, Avance Nerve Graft, Axoguard Nerve Protector |
| Spinal Simplicity, LLC | $18.89 | 2024 | Ha Minuteman G3-R |
| Orthofix Medical, INC. | $17.09 | 2022 | |
| Integrity Implants INC. Dba Accelus | $14.97 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chima Ohaegbulam listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.